Reducing Risk: 5 Steps for a Fearless Launch
In this webinar, we’ll discuss five of the largest risks associated with launch. Our experts will explain the concrete steps your team can take to mitigate those risks in advance—so you can launch your therapy without fear of failure.
Access the Webinar
Best Practices in Market Access
These free on-demand webinars offer advice on how to plan, execute and assess your commercial strategy, from MMIT’s market access experts.
Previous Webinar Sessions
In this webinar, we’ll explain how MMIT, with NorstellaLinQ, developed a robust, unified dataset to provide comprehensive insights into a rare disease population.
In this webinar, learn how best practices for targeting and engaging physicians both in-person and via non-personal promotion techniques.
In the immediate post-launch timeframe, pharma companies can use market access research to improve coverage and utilization. In this webinar, our experts explain the benefits of everything from post-label indication research to competitor analyses and payer/IDN perception tracking.
In this webinar, learn what kinds of market access research pharma companies should complete in the six to twelve months before launch to strengthen their performance.
In this BioPharma Dive webinar, Dinesh Kabaleeswaran, SVP of Consulting and Advisory Services at MMIT, and Jen Klarer, partner and head of Cell & Gene Therapy at The Dedham Group, explain the results of our 2024 State of Patient Access Survey.